Key facts
- This page summarizes Morgan E. Obrien's Form 4 filing for Anterix Inc. (ATEX).
- 7 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 15 Mar 2023, 18:04.
Morgan E. Obrien - 13 Mar 2023 Form 4 Insider Report for Anterix Inc. (ATEX)
- Reporting relationship
- Executive Chairman, Director
- Issuer ticker
- ATEX
- Reported as of
- 13 Mar 2023
- Net transaction value
- -$496,973
- SEC form
- 4
- Accepted by SEC
- 15 Mar 2023, 18:04:20 UTC
- Prior SEC filing
- 06 Dec 2022
- Next SEC filing
- 22 May 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Gena Ashe, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Morgan E. Obrien filed Form 4 for Anterix Inc. (ATEX) on 15 Mar 2023.
Change
- Previous filing in this sequence was filed on 06 Dec 2022.
- Current net transaction value: -$496,973.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ATEX
transaction
Common Stock
Options Exercise
- Transaction value
- $400,000
- Shares
- +20,000
- Change %
- +63%
- Price
- $20.00
- Shares after
- 51,947
- Date
- 13 Mar 2023
- Ownership
- Direct
ATEX
transaction
Common Stock
Options Exercise
- Transaction value
- $455,000
- Shares
- +20,000
- Change %
- +39%
- Price
- $22.75
- Shares after
- 71,947
- Date
- 13 Mar 2023
- Ownership
- Direct
ATEX
transaction
Common Stock
Sale
- Transaction value
- $151,473
- Shares
- -5,000
- Change %
- -6.9%
- Price
- $30.29
- Shares after
- 66,947
- Date
- 13 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
ATEX
transaction
Common Stock
Sale
- Transaction value
- $1,200,500
- Shares
- -40,000
- Change %
- -60%
- Price
- $30.01
- Shares after
- 26,947
- Date
- 13 Mar 2023
- Ownership
- Direct
- Footnotes
- F2
ATEX
transaction
Common Stock
Gift
- Transaction value
- $0
- Shares
- -1,000
- Change %
- -3.7%
- Price
- $0.000000
- Shares after
- 25,947
- Date
- 12 Oct 2022
- Ownership
- Direct
- Footnotes
- F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ATEX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -20,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 13 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $20.00
- Footnotes
- F4
ATEX
transaction
Derivative
Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -20,000
- Change %
- -36%
- Price
- $0.000000
- Shares after
- 34,945
- Date
- 13 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,000
- Exercise price
- $22.75
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $29.79 to $30.56. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Footnote F2
This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $29.77 to $30.28. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Footnote F3
These transactions represent a charitable contribution by the Reporting Person.
Footnote F4
The option shares are fully vested.